The stem cell origin of CML has been recently confirmed using a stem-cell based animal model in which expression of the BCR-ABLp210 oncogene is restricted to the stem cell stage of development in a genetically engineered mouse [43, 46]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.